| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |